North Shore University Hospital’s cardiology team became the first to complete a procedure using the novel OmniaSecure ...

Dr. Richard Page answers the question: 'Are There Defibrillators Without Leads?' — -- Question: I have heard that some defibrillators may not need leads to be placed in the heart. Is this true, ...

There is a warning for people with implantable defibrillators to help control their hearts — some of the devices are breaking down. Defibrillators placed inside patients’ chests have helped thousands ...

AtaCor, a cardiac rhythm management (CRM) company, develops extravascular defibrillation technologies. Its offerings aim to ...

Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed ...

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025: ...

BOSTON — An investigative small-diameter defibrillation lead for implantable cardioverter-defibrillators has exceeded its safety and efficacy expectations in a pivotal clinical trial. The LEADR trial ...

Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm Implantable cardioverter defibrillators (ICDs ...

Some patients are having their defibrillation leads taken out early due to shock coil calcification, according to an FDA alert. Boston Scientific has informed healthcare providers that device leads ...

Please provide your email address to receive an email when new articles are posted on . A novel defibrillation lead beat safety and efficacy goals in a pivotal trial. The goal of physicians is for the ...

Medical-device startups are booming these days, as VCs throw money at everything from artificial spinal-disc fillers to implantable weight-control “neuromodulators” to vacuum devices that suck blood ...

TEL AVIV (MarketWatch) -- Medtronic Inc., the Minneapolis medical-technology company, said on Monday that it would voluntarily suspend distribution of the Sprint Fidelis family of defibrillation leads ...